GLAXOSMITHKLINE PLC

GSK
Delayed Quote. Delayed  - 10/21 11:35:27 am
1410.8GBX +0.26%

Turn to zoom
Prev.1407.2000
Open1410.0000
High1414.0000
Low1401.7500
Volume5 270 230
Latest news
20h ago
1d ago
1d ago
1d ago
Chart GLAXOSMITHKLINE PLC
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralBullish
Resistance1 4291 5261 515
Spread/Res.-1,3%-7,5%-6,9%
Spread/Supp.2,2%6,1%5,0%
Support1 3801 3301 344
Financials
Sales 2021 33 519 M 46 242 M 46 242 M
Net income 2021 3 787 M 5 224 M 5 224 M
Net Debt 2021 21 074 M 29 073 M 29 073 M
P/E ratio 2021 18,5x
Yield 2021 5,67%
Capitalization 70 610 M 97 491 M 97 413 M
EV / Sales 2021 2,74x
EV / Sales 2022 2,56x
Nbr of Employees 94 066
Free-Float 92,3%
Company
GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology...

>> Read more
Sector :
Other Pharmaceuticals
Calendar :
2021-10-27 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 1 410,80 GBX
Average target price 1 602,73 GBX
Spread / Average Target 13,6%